PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Benefits of increased health care transparency hinge on reliable and valid information, says ACP

2010-09-20
(Press-News.org) (Washington) In a policy paper released today the American College of Physicians reaffirmed its support for increased health care transparency. Healthcare Transparency—Focus on Price and Clinical Performance Information, the first paper in a series of policy papers about transparency, is an introduction and overview of the issues and challenges faced with increased health care transparency.

"We believe that increasing transparency in the health care system can be beneficial to both patients and physicians," said J. Fred Raslton, Jr., MD, FACP, president of ACP. "However, unless the transparency information that is collected meets certain criteria it will not accomplish the goal of improving health care."

The college believes that for the potential benefits of health care transparency to be realized the reported information must be: reliable and valid; transparent in its development; open to prior review and appeal by the physicians and other health care professionals referenced; minimally burdensome to the reporting physician or other health care professional; and, comprehensible and useful to its intended audience, including a clear statement of its limitations.

The policy paper lays out 13 new recommendations for how these goals for health care transparency can be met. The recommendations are broken into two different areas of transparency information: price transparency and clinical performance transparency.

In increasing the use of price transparency, the College believes that the following recommendations are essential: ACP supports the goal of price transparency for services and products provided by all health care stakeholders to patients/consumers. Any methodology used to publicly report price is also transparent, and contains adequate protections to ensure the reporting of reliable and valid price information. Price information provided to patients/consumers should be readily available, presented in a manner that is easily understood and reflective of its limitations. Any formal governmental or private sector requirements for price transparency minimize the administrative burden on the participating physicians or other healthcare professionals. Price should never be used as the sole criterion for choosing a physician or any other healthcare professional. Price should only be considered along with the explicit consideration of the quality of services delivered and/or the effectiveness of the intervention.

In increasing the use of clinical performance transparency, the College advocates that the following recommendations: ACP supports the goal of performance transparency for services and products provided by all healthcare stakeholders to patients/consumers. The College also reaffirms and expands upon the qualities of a good performance measure as reported in the ACP policy paper, "Linking Physician Payment to Quality Care." The College highlights the importance of "process transparency" in the public reporting of healthcare performance information—the explicit delineation of the methodology and evidence base used to develop the measures being reported. The College reaffirms the importance of physicians and other healthcare professionals having timely access to assessed performance information prior to public reporting and the availability of a fair and accurate appeals process to examine potential inaccuracies as reflected in the ACP policy paper "Developing a Fair Process through which Physicians Participating in Performance Measurement Programs can Request a Reconsideration of Their Rating." The College reaffirms the "ACP Policy Statement Pertaining to Health Plan Programs to Rate Physicians" and recommends that the expansion of public reporting of physician performance differences takes into account the technical capability to report reliable, valid and useful differences. The College supports the use of standardized performance measures and data collection methodology, consensually agreed upon by relevant nationally recognized healthcare stakeholders, in efforts to publicly report the performance of physician and other healthcare professionals. In addition, the College supports the collection of both public and private data by trusted third party entities so that physician and other clinician's performance can be assessed as comprehensively as possible. The College, while recognizing and supporting the increased patient/consumer interest in obtaining and providing physician performance information, does not support the use of web-based physician rating sites that rely on subjective and invalidated data, and do not meet the College's standards for physician performance measurement. The College supports increased efforts to determine and employ the most effective means of presenting performance information to patients/consumers, and to educate these information users on the meaning of performance differences among physicians, hospitals and other providers and on how to effectively use this information to make informed healthcare choices.

"Until they have access to accurate and useful information about what they are purchasing, both regarding price and clinical performance, concluded Dr. Ralston, "patients will not have the ability to make truly informed decisions regarding their health care."

INFORMATION:

The American College of Physicians (www.acponline.org) is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 130,000 internal medicine physicians (internists), related subspecialists, and medical students. Internists specialize in the prevention, detection, and treatment of illness in adults. Follow ACP on Twitter (www.twitter.com/acpinternists) and Facebook (www.facebook.com/acpinternists).

END



ELSE PRESS RELEASES FROM THIS DATE:

Compound boosts marijuana-like chemical in the body to relieve pain at injury site

2010-09-20
Irvine, Calif., Sept. 20, 2010 — American and Italian researchers have found that a novel drug allows anandamide – a marijuana-like chemical in the body – to effectively control pain at the site of an injury. Led by Daniele Piomelli, the Louise Turner Arnold Chair in Neurosciences and director of the Center for Drug Discovery at UC Irvine, the study suggests that such compounds could form the basis of pain medications that don't produce sedation, addiction or other central nervous system side effects common with existing painkillers, such as opiates. "These findings ...

Scientists show Six3 gene essential for retinal development

2010-09-20
New research led by St. Jude Children's Research Hospital investigators adds to evidence that the Six3 gene functions like a doorman in the developing brain and visual system, safeguarding the future retina by keeping the region where the eye is forming free of a signaling protein capable of disrupting the process. The findings underscore the pivotal role Six3 plays in the developing nervous system as a key regulator of the Wnt family of signaling proteins and expands on earlier work from the laboratory of Guillermo Oliver, Ph.D., member of the St. Jude Department of ...

Millions with voice problems don't know treatment available

2010-09-20
DURHAM, N.C.—Two-thirds of Americans with voice problems don't seek medical care either because they don't know treatment is available or because they think the problem will just go away, according to a new study conducted at the Duke Voice Care Center. That's concerning, says Seth Cohen, MD, an otolaryngologist at Duke. "Voice disorders aren't benign nuisances that just go away. They are symptoms of a range of medical conditions from allergies to cancer. When caught early, the right treatment can make a big difference. Left untreated, they can become chronic problems ...

New pathway regulates immune balance and offers promising drug development target

2010-09-20
St. Jude Children's Research Hospital scientists have identified a new pathway that helps control the immune balance through reciprocal regulation of specialized T lymphocytes, which play very different inflammatory roles. Investigators also determined that two drugs working in different ways to dampen the inflammatory response in patients with multiple sclerosis or following organ transplantation target this new mechanism. Further research into the pathway might lead to new medications to block other autoimmune disorders or to new anti-rejection drugs, researchers said. ...

USC lab releases smartphone app that measures particulate air pollution

USC lab releases smartphone app that measures particulate air pollution
2010-09-20
University of Southern California computer scientists have found a way to combine smartphone resources with a novel application that allows the phones' users to help monitor air quality. The application, provisionally titled "Visibility," is available for download at http://robotics.usc.edu/~mobilesensing/Projects/AirVisibilityMonitoring The researchers, from the USC Viterbi School of Engineering, hope that as many users as possible download and try it in order to improve the software. Currently, the download works for smartphones running the Android system and soon ...

Mayo-led researchers discover genetic variants modifying breast cancer risk

2010-09-20
ROCHESTER, Minn. -- Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic researchers show that some of those persons may possess additional genetic variants that modify their risk. These new findings enhancing individualized medicine appear in the current Nature Genetics. "These findings should be useful in helping determine individual risk for breast cancer in BRCA1 carriers," says Fergus Couch, Ph.D., Mayo ...

4 possible risk factors for ovarian cancer found

2010-09-20
ROCHESTER, Minn. -- A consortium of cancer researchers has identified four chromosome locations with genetic changes that are likely to alter a woman's risk of developing ovarian cancer. The findings appear in Nature Genetics in an article authored by a Mayo Clinic researcher. Researchers say that while more needs to be learned about the function of the specific chromosomal regions involved in susceptibility, the discoveries move them a major step closer to individualized risk assessments for ovarian cancer. In the future, women at greatest risk due to these and other ...

Technology in the extreme

2010-09-20
Radio transmitters that can withstand temperatures of up to 900 oC could soon be dropped into the depths of the earth to provide early warning of a volcanic eruption. The state-of-the-art technology being pioneered by experts at Newcastle University uses Silicon Carbide electronics that can withstand temperatures equal to the inside of a jet engine. Measuring subtle changes in the levels of key volcanic gases such as carbon dioxide and sulphur dioxide, the wireless sensor would feed back real-time data to the surface, providing vital information about volcanic activity ...

2 studies find new genetic links to ovarian cancer risk

2010-09-20
DURHAM, N.C. – An international consortium of scientists has discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population, according to two separate studies published today (Sunday), online in Nature Genetics. The consortium, including scientists from the U.S., Europe, Canada and Australia, based the new work on their earlier research comparing 10,283 women with ovarian cancer to 13,185 women without the disease. That effort had found a stretch of DNA on chromosome 9 containing single DNA letter variations ...

Possible alternate therapy for adults with poorly controlled asthma

2010-09-20
A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. "This study's results show that tiotropium bromide might provide an alternative to other asthma treatments, expanding options available to patients for controlling their asthma," said NHLBI Acting Director Susan B. Shurin, M.D. "The goal in managing ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Benefits of increased health care transparency hinge on reliable and valid information, says ACP